FOLH1 and prostate neoplasm: The DR of <sup>18</sup>F-PSMA-1007 PET/CT was slightly higher in primary prostate tumors than in biochemical recurrence.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD42022331595.